Mersana Therapeutics, Inc. (19)

Browse by Contract Category

Contracts

Form of Restricted Stock Unit under the 2017 Stock Incentive Plan (Filed With SEC on August 6, 2021)
Amended and Restated Offer Letter, by and between Mersana Therapeutics, Inc. and Michael Kaufman, dated March 8, 2017 (Filed With SEC on May 10, 2021)
Eighth Lease Modification Agreement to the Lease Between Rivertech Associates II LLC and Mersana Therapeutics, Inc., effective as of April 5, 2021, by and between Mersana... (Filed With SEC on May 10, 2021)
Second Amendment to Loan and Security Agreement, dated August 28, 2020, by and between Mersana Therapeutics, Inc, and Silicon Valley Bank (Filed With SEC on September 3, 2020)
Commercial License and Option Agreement (Filed With SEC on August 7, 2020)
Offer Letter, by and between Mersana Therapeutics, Inc. and Arvin Yang, dated November 5, 2020 (Filed With SEC on May 10, 2021)
Underwriting Agreement, dated May 28, 2020, among Mersana Therapeutics, Inc. and Cowen and Company, LLC and SVB Leerink LLC, as representatives of the several underwriters listed... (Filed With SEC on June 1, 2020)
Offer Letter, by and between Mersana Therapeutics, Inc. and Dirk Huebner, dated November 5, 2018 (Filed With SEC on May 8, 2020)
Offer Letter, by and between Mersana Therapeutics, Inc. and Brian DeSchuytner, dated June 10, 2019 (Filed With SEC on May 8, 2020)
Seventh Lease Extension and Modification Agreement to the Lease Between Rivertech Associates II LLC and Mersana Therapeutics, Inc. dated March 10 2020, by and between Mersana... (Filed With SEC on May 8, 2020)
Description of Registrants Common Stock (Filed With SEC on February 28, 2020)
Exchange Agreement between Mersana Therapeutics, Inc. and Biotechnology Value Fund, L.P., Biotechnology Value Fund II, L.P. and Biotechnology Value Trading Fund OS, L.P., dated... (Filed With SEC on November 27, 2019)
Form of Exchange Warrant (Filed With SEC on November 27, 2019)
First Amendment to the License, Development and Commercialization Agreement dated August 19, 2019, by and between Mersana Therapeutics, Inc. and Recepta Biopharma, S.A (Filed With SEC on November 6, 2019)
First Amendment to Loan and Security Agreement, dated June 21, 2019, by and between Mersana Therapeutics, Inc. and Silicon Valley Bank (Filed With SEC on August 8, 2019)
Loan and Security Agreement dated May 8, 2019, by and between Mersana Therapeutics, Inc. and Silicon Valley Bank (Filed With SEC on August 8, 2019)
Offer Letter, by and between Mersana Therapeutics, Inc. and David Spellman, dated December 18, 2017 (Filed With SEC on May 9, 2019)
Loan and Security Agreement dated May 8, 2019, by and between Mersana Therapeutics, Inc. and Silicon Valley Bank (Filed With SEC on May 9, 2019)
Underwriting Agreement, dated February 28, 2019, by and among Mersana Therapeutics, Inc. and SVB Leerink LLC, as the representative of the several underwriters listed on Schedule... (Filed With SEC on March 4, 2019)